Euclises Pharmaceuticals, Inc.
Industry
- Biotechnology
- Drug Discovery Technologies
- ADMET
- Drug Discovery Technologies
- Pharmaceuticals
Latest on Euclises Pharmaceuticals, Inc.
So you are looking for an A round in 2015? What are your chances and how should you maximize them? What can you learn from the A-List class of 2014? Of course, you should have a backable project. Look
Start-Up Execs Arvinas Inc. Manuel Litchman, MD To: Pres. & CEO (January) From: SVP & Global Program Head, Novartis Pharmaceuticals Phone: 203-535-1456 Augmenix Inc. Ken Knudson To: VP, Gl
New At The Helm Company Changes ASHBURN , Theodore T., MD, PhD To: Dicerna Pharmaceuticals Inc. , SVP, Product Strategy & Ops. (December) From: Genzyme/Sanofi Oncology, Global Product Leader, Le
[BriteSeed] 875 North Michigan Avenue Suite 3100 Chicago, IL 60611 Phone: (312) 772-4027 Email: info@briteseed.com Web Site: www.briteseed.com Management: Paul Fehrenbacher, Muneeb Bokhari, J